MRNA - Spark Newswire

2 minute read

This Is What Whales Are Betting On Moderna

Today, 3:33 AM

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

MRNA

7 minute read

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30

By Akanksha Bakshi

Today, 3:33 AM

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

AAPL

3 minute read

Nasdaq Futures Fly As Wall Street Looks Set To Rebound From 2-Session Losses — Twitter, Best Buy And These Stocks In Focus

By Shanthi Rexaline

Today, 3:33 AM

U.S. stocks look set to see a turnaround on Tuesday, potentially reversing some of the losses incurred in the previous two trading sessions.

BBY

3 minute read

US Stock Futures Higher Ahead Of Economic Data, Fed Speakers

By Lisa Levin

Today, 3:33 AM

Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the Nasdaq Composite dropping around 1% in the previous session.

BBY

2 minute read

Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report

By Shanthi Rexaline

Today, 3:33 AM

Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.

BNTX

1 minute read

FDA
News

U.S. FDA Expected To Authorize A Pair Of Booster Shots Targeting What Appear To The Virus’ Most Contagious Strains As Soon As Wednesday

By Michael Horton

Today, 3:33 AM

-Reuters

BNTX

1 minute read

Switzerland Approves First Next-Generation Bivalent COVID-19 Booster Vaccine

By Vandana Singh

Today, 3:33 AM

Switzerland’s regulatory authority has granted conditional approval for Moderna Inc’s (NASDAQ:MRNA) omicron-targeting bivalent booster vaccine for adults 18 years and older. Spikevax…

MRNA

2 minute read

What Are Whales Doing With Moderna

By Benzinga Insights

Today, 3:33 AM

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

MRNA